BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Dr. Lex Van der Ploeg Has Been Elected to the Neurotez, Inc. Board of Directors


6/15/2012 10:12:31 AM

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Neurotez is announcing the appointment of Dr. Lex Van der Ploeg to the Board of Directors. Dr. Van der Ploeg will continue as Chief Scientific Advisor for Neurotez’s development plans, and will now also participate as a member of the Board of Directors. Dr. Van der Ploeg has in depth knowledge in the Neurosciences, Obesity and Oncology, applied through translational research/drug discovery, and drug development efforts at diverse pharmaceutical companies. “Lex’s background and experience are an exceptional fit for Neurotez as we move forward with our clinical efforts. Our primary program to develop Leptin for the treatment of Alzheimer’s disease, and our overarching mission as a biotech, will significantly benefit with Lex on board” said Nikolaos Tezapsidis, President & CEO of Neurotez, Inc. “I am excited about Neurotez’s programs, and the unique mechanisms which Leptin modulates for the treatment of Alzheimer’s disease” stated Lex Van der Ploeg.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES